Chinese Journal of Antituberculosis ›› 2026, Vol. 48 ›› Issue (9): 1436-1443.doi: 10.19982/j.issn.1000-6621.20260060
• Review Articles • Previous Articles Next Articles
Song Juemin, Shi Liang(
), Liang Bianxiang, Kang Hui
Received:2026-01-29
Online:2026-09-10
Published:2026-09-08
Contact:
Shi Liang
E-mail:243865115@qq.com
Supported by:CLC Number:
Song Juemin, Shi Liang, Liang Bianxiang, Kang Hui. Research progress on novel detection techniques for HIV-associated tuberculosis[J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1436-1443. doi: 10.19982/j.issn.1000-6621.20260060
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20260060
| [1] | World Health Organization. Global tuberculosis report 2025[R]. Geneva: World Health Organization, 2025. |
| [2] | Liu E, Wang Q, Zhang G, et al. Tuberculosis/HIV Coinfection and Treatment Trends-China, 2015-2019[J]. China CDC Wkly, 2020, 2(48):924-928. doi:10.46234/ccdcw2020.252. |
| [3] | Bates M, Mudenda V, Shibemba A, et al. Burden of tuberculosis at post mortem in in-patients at a tertiary referral centre in sub Saharan Africa: a prospective descriptive autopsy study[J]. Lancet Infect Dis, 2015, 15(5):544-551. doi:10.1016/S1473-3099(15)70058-7. |
| [4] | 中国性病艾滋病防治协会HIV合并结核病专业委员会, 沈银忠, 卢洪洲. HIV/AIDS患者合并结核病诊治专家共识(2025年版)[J]. 中国艾滋病性病, 2025, 31(11):1278-1286. doi:10.13419/j.cnki.aids.2025.11.20. |
| [5] | Steingart K R, Schiller I, Horne D J, et al. Xpert® MTB/RIF assay for pulmonary tuber-culosis and rifampicin resistance in adults[J]. Cochrane Database Syst Rev, 2014, 2014(1): CD009593. doi:10.1002/14651858. |
| [6] |
Pink F, Brown T J, Kranzer K, et al. Evaluation of Xpert MTB/RIF for detection of Mycobacterium tuberculosis in cerebrospinal fluid[J]. J Clin Microbiol, 2016, 54(3):809-811. doi:10.1128/JCM.02806-15.
pmid: 26763963 |
| [7] | Opota O, Mazza-Stalder J, Greub G, et al. The rapid mo-lecular test Xpert MTB/RIF ultra: towards improved tuberculosis diagnosis and rifampicin resistance detection[J]. Clin Microbiol Infect, 2019, 25(11):1370-1376. doi:10.1016/j.cmi.2019.03.021. |
| [8] | World Health Organization. WHO operational handbook on tuberculosis. Module 3: diagnosis-rapid diagnostics for tuberculosis detection, 2021 update[M/OL]. Geneva: World Health Organization, 2021. |
| [9] | Donovan J, Cresswell F V, Thuong N T T, et al. Xpert MTB/RIF ultra for the diagnosis of tuberculous meningitis: a small step forward[J]. Clin Infect Dis, 2020, 71(8):2002-2005. doi:10.1093/cid/ciaa473. |
| [10] | Esmail A, Tomasicchio M, Meldau R, et al. Comparison of Xpert MTB/RIF (G4) and Xpert Ultra,including trace readouts, for the diagnosis of pulmonarytuberculosis in a TB and HIV endemic setting[J]. Int J InfectDis, 2020, 95:246-252. doi:10.1016/j.ijid.2020.03.025. |
| [11] | Lin T H, Chung H Y, Jian M J, et al. Nationwide longitudinal evaluation of a machine learning approach for enhanced interpretation of Xpert MTB/RIF ultra rifampicin-resistance results in low bacterial load tuberculosis specimens[J]. J Infect Public Health, 2026, 19(2): 103064. doi:10.1016/j.jiph.2025.103064. |
| [12] | Kasule G W, Hermans S, Acacio S, et al. Stool4TB Global Partnership. Performance of stool Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis among adults living with HIV: a multicentre, prospective diagnostic study[J]. Lancet Microbe, 2025, 6(7):101085. doi:10.1016/j.lanmic.2025.101085. |
| [13] | Mori Y, Kanda H, Notomi T. Loop-mediated isothermal amplification (LAMP): recent progress in research and develop-ment[J]. J Infect Chemother, 2013, 19(3):404-411. doi:10.1007/s10156-013-0590-0. |
| [14] |
Muriithi B, Bundi M M, Moriyasu T, et al. Applicability of TB-LAMP test for diagnosis of pulmonary TB among HIV-positive individuals[J]. IJTLD Open, 2025, 2(1):26-32. doi:10.5588/ijtldopen.24.0410.
pmid: 39802227 |
| [15] |
Nakiyingi L, Nakanwagi P, Briggs J, et al. Performance of loop-mediated Isothermal amplification assay in the diagnosis of pulmonary tuberculosis in a high prevalence TB/HIV rural setting in Uganda[J]. BMC Infect Dis, 2018, 18(1): 87. doi:10.1186/s12879-018-2992-1.
pmid: 29466946 |
| [16] | World Health Organization. The use of loop-mediated isothermalamplification (TB-LAMP) for the diagnosis of pulmonary tuberculosis[R]. Geneva: World Health Organization, 2016. |
| [17] |
Nikolayevskyy V, Kranzer K, Niemann S, et al. Whole genome sequencing of Mycobacterium tuberculosis for detection of recent transmission and tracing outbreaks: a systematic review[J]. Tuberculosis, 2016, 98:77-85. doi:10.1016/j.tube.2016.02.009.
pmid: 27156621 |
| [18] | Papaventsis D, Casali N, Kontsevaya I, et al. Whole genome sequencing of Mycobacterium tuberculosis for detection of drug resistance: a systematic review[J]. Clin Microbiol Infect, 2017, 23(2):61-68. doi:10.1016/j.cmi.2016.09.008. |
| [19] | Chen J S, Ma E, Harrington L B, et al. CRISPR-Cas12a target binding unleashes indis-criminate single-stranded DNase activity[J]. Science, 2018, 360(6387):436-439. doi:10.1126/science.aar6245. |
| [20] | Sam I K, Chen Y Y, Ma J, et al. TB-QUICK: CRISPR-Cas12b-assisted rapid and sensitive detection of Mycobacterium tuberculosis[J]. J Infect, 2021, 83(1):54-60. doi:10.1016/j.jinf.2021.04.032. |
| [21] | Abdulgader S M, Chiwaya A M, Nwamba W V, et al. Diagnostic accuracy of Truenat MTB Ultima on sputum for pulmonary tuberculosis diagnosis in an HIV-endemic setting[J]. Clin Microbiol Infect, 2025, 31(7):1203-1209. doi:10.1016/j.cmi.2025.04.013. |
| [22] | Luetkemeyer A F, Kendall M A, Wu X, et al. Evaluation of two line probe assays for rapid detection of Mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB Mycobacteria in HIV-infected individuals with suspected TB[J]. J Clin Microbiol, 2014, 52(4):1052-1059. doi:10.1128/JCM.02639-13. |
| [23] | Zhang M, Zhang H, Yan B, et al. Diagnostic performance of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) in bronchoalveolar lavage fluid for pulmonary tuberculosis in HIV-infected patients[J]. J Clin Tuberc Other Mycobact Dis, 2024, 36:100459. doi:10.1016/j.jctube.2024.100459. |
| [24] | Sun J, Han X, Yan H, et al. Advances in technology for the laboratory diagnosis of individuals with HIV/AIDS coinfected with Mycobacterium tuberculosis[J]. Biosaf Health, 2024, 6(3):133-142. doi:10.1016/j.bsheal.2024.04.003. |
| [25] | Bjerrum S, Broger T, Székely R, et al. Diagnostic accuracy of a novel and rapid lipoarabinomannan test for diagnosing tuberculosis among people with human immunodeficiency virus[J]. Open Forum Infect Dis, 2019, 7(1):ofz530. doi:10.1093/ofid/ofz530. |
| [26] | Bjerrum S, Schiller I, Dendukuri N, et al. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV[J]. Cochrane Database Syst Rev, 2019, 10(10):CD011420. doi:10.1002/14651858.CD011420. |
| [27] |
Broger T, Sossen B, du Toit E, et al. Novel lipoarabinomannan point-of-care tuberculosis test for people with HIV: a diagnostic accuracy study[J]. Lancet Infect Dis, 2019, 19(8):852-861. doi:10.1016/S1473-3099(19)30001-5.
pmid: 31155318 |
| [28] | Pan L, Huang M, Jia H, et al. Diagnostic Performance of a Novel CXCL10 mRNA Release Assay for Mycobacterium tuberculosis Infection[J]. Front Microbiol, 2022, 30(13):825413. doi:10.3389/fmicb.2022.825413. |
| [29] | Tang Y, Yu Y, Wang Q, et al. Evaluation of the IP-10 mRNA release assay for diagnosis of TB in HIV-infected individuals[J]. Front Cell Infect Microbiol, 2023, 13:1152665. doi:10.3389/fcimb.2023.1152665. |
| [30] |
Jeong Y H, Hur Y G, Lee H, et al. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production[J]. J Clin Microbiol, 2015, 53(2):504-510. doi:10.1128/JCM.02758-14.
pmid: 25428147 |
| [31] |
Wergeland I, Pullar N, Assmus J, et al. IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy[J]. J Infect, 2015, 70(4):381-391. doi:10.1016/j.jinf.2014.12.019.
pmid: 25597826 |
| [32] | Ning B, Chandra S, Pan Y, et al. Self-powered rapid antigen-specific T-cell response assay for Mycobacterium tuberculosis infections[J]. Nat Biomed Eng, 2026, 10(1):69-79. doi:10.1038/s41551-025-01441-5. |
| [33] |
Zhang H, Li L, Liu Y, et al. Serum cytokine biosignatures for identification of tuberculosis among HIV-positive inpatients[J]. Thorax, 2024, 79(5): 465-471. doi:10.1136/Thorax-2023-220782.
pmid: 38490721 |
| [34] | 姚明旭, 王泽琦, 宋瑞雪, 等. 结核抗原特异细胞因子在 HIV 感染者中诊断结核病的临床价值评估[J]. 中国防痨杂志, 2025, 47(5):605-612. doi:10.19982/j.issn.1000-6621.20250039. |
| [35] | Kasule G W, Hermans S, Semugenze D, et al. Stool4TB Global Partnership. Non-sputum-based samples and biomarkers for detection of Mycobacterium tuberculosis: the hope to improve childhood and HIV-associated tuberculosis diagnosis[J]. Eur J Med Res, 2024, 29(1):502. doi:10.1186/s40001-024-02092-z. |
| [36] | LaCourse S M, Seko E, Wood R, et al. Diagnostic performance of oral swabs for non-sputum based TB diagnosis in a TB/HIV endemic setting[J]. PLoS One, 2022, 17(1): e0262123. doi:10.1371/journal.pone0262123. |
| [37] | Shapiro A E, Olson A M, Kidoguchi L, et al. Complementary Nonsputum Diagnostic Testing for Tuberculosis in People with HIV Using Oral Swab PCR and Urine Lipoarabinomannan Detection[J]. J Clin Microbiol, 2022, 60(8):e0043122. doi:10.1128/jcm.00431-22. |
| [38] | Phillips M, Cataneo R N, Condos R, et al. Volatile biomarkers of pulmonary tuberculosis in the breath[J]. Tuberculosis (Edinb), 2007, 87(1):44-52. doi:10.1016/j.tube.2006.03.004. |
| [39] |
Badola M, Agrawal A, Roy D, et al. Volatile Organic Compound Identification-Based Tuberculosis Screening among TB Suspects: A Diagnostic Accuracy Study[J]. Adv Respir Med, 2023, 91(4):301-309. doi:10.3390/arm91040024.
pmid: 37489387 |
| [40] | Phillips M, Basa-Dalay V, Blais J, et al. Point-of-care breath test for biomarkers of active pulmonary tuberculosis[J]. Tuberculosis(Edinb), 2012, 92(4):314-320. doi:10.1016/j.tube.2012.04.002. |
| [41] | Mosquera-Restrepo S F, Zuberogoïtia S, Gouxette L, et al. A Mycobacterium tuberculosis fingerprint in human breath allows tuberculosis detection[J]. Nat Commun, 2022, 13(1): 7751. doi:10.1038/s41467-022-35453-5. |
| [42] |
Nabeemeeah F, Sabet R, Moloantoa T, et al. Exhaled breath specimens subjected to point-of-care lipoarabinomannan testing[J]. Int J Tuberc Lung Dis, 2023, 27(9):703-705. doi:10.5588/ijtld.23.0128.
pmid: 37608487 |
| [43] | Musisi E, Ssesolo A, Sloan D J, et al. Detection and quantification of viable Mycobacterium tuberculosis bacilli in saline-processed stool samples by tuberculosis molecular bacterial load assay: a potential alternative for processing stool[J]. Microbiol Spectr, 2022:e0027422. doi:10.1128/spectrum.00274-22. |
| [44] |
Sabiiti W, Azam K, Farmer E C W, et al. Tuberculosis bacillary load, an early marker of disease severity: the utility of tuberculosis Molecular Bacterial Load Assay[J]. Thorax, 2020, 75(7):606-608. doi:10.1136/thoraxjnl-2019-214238.
pmid: 32354738 |
| [45] | DiNardo A R, Kay A W, Maphalala G, et al. Diagnostic and treatment monitoring potential of a stool-based quantitative polymerase chain reaction assay for pulmonary tuberculosis[J]. Am J Trop Med Hyg, 2018, 99(2):310-316. doi:10.4269/ajtmh.18-0004. |
| [46] | Musisi E, Sessolo A, Kaswabuli S, et al. High Mycobacterium tuberculosis bacillary loads detected by tuberculosis molecular bacterial load assay in patient stool: a potential alternative for nonsputum diagnosis and treatment response monitoring of tuberculosis[J]. Microbiol Spectr, 2022, 10(1): e0210021. doi:10.1128/spectrum.02100-21. |
| [47] | Suparmin S, Indrasari N D, Renaldi K, et al. Diagnostic role of stool TB-PCR in suspected tuberculous colitis patient at Dr Cipto Mangunkusumo National Central General Hospital:a cross-sectional study[J]. Pan Afr Med J, 2022, 42:262. doi:10.11604/pamj.2022.42.262.22293. |
| [48] | 韩婷婷, 陈秋奇, 邓国防. 宿主转录标志物GBP5、DUSP3和KLF2的研究进展[J]. 中国防痨杂志, 2022, 44(2):193-196. doi:10.19982/j.issn.1000-6621.20210660. |
| [49] | Huynh J, Nhat L H T, Bao N L H, et al. The Ability of a 3-Gene Host Signature in Blood to Distinguish Tuberculous Meningitis From Other Brain Infections[J]. J Infect Dis, 2024, 230(2):e268-e278. doi:10.1093/infdis/jiad606. |
| [50] | Roe J K, Thomas N, Gil E, et al. Blood transcriptomic diagnosis of pulmonary and extrapulmonary tuberculosis[J]. JCI Insight, 2016, 1(16):e87238. doi:10.1172/jci.insight.87238. |
| [51] | Sung J, Kitonsa P J, Nalutaaya A, et al. Performance of universal and stratified computer-aided detection thresholds for chest x-ray-based tuberculosis screening: a cross-sectional, diagnostic accuracy study[J]. Lancet Digit Health, 2025, 7(12):100934. doi:10.1016/j.landig.2025.100934. |
| [52] | Burke R M, Nyirenda S K, Mtenga T, et al. Enhanced Tuberculosis Diagnosis With Computer-aided Chest X-ray and Urine Lipoarabinomannan in Adults With HIV Admitted to Hospital (CASTLE Study): A Cluster Randomized Trial[J]. Clin Infect Dis, 2025, 80(5):1143-1151. doi:10.1093/cid/ciae273. |
| [1] | Zhong Leping, Qin Shibing, Sha Wei, Deng Guofang, Lin Minggui. Application and prospect of ultrasound-mediated transdermal drug delivery in adjuvant treatment of tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1245-1249. |
| [2] | Huang Huan, Wang Xiaomin, Song Zhe, Li Xuelin, Ding Feng, Wang Jin, Zeng Jianfeng, Wu Haiwu, Zhong Xinguang, Lu Shuihua. Interpretation of the World Health Organization’s Target Product Profiles for Tuberculosis Screening Test Products [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1250-1258. |
| [3] | Ren Feilin, Jin Meihua, Tong Zhaowei, Zheng Pingming. Interpretation of the Group Standard Specifications for the Construction of Tuberculosis Preventive Treatment Clinics in Primary Medical Institutions [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1259-1265. |
| [4] | Bai Yan, Chen Yu, Gao Xusheng, Liang Jianqin, Zeng Yi, Wang Yun, Fan Lin. Analysis of clinical characteristics and factors influencing outcomes in elderly patients with drug-susceptible pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1266-1276. |
| [5] | Li Cheng, Wu Chunli, Xia Fan, Yu Wenduo, Liu Zhenguo, Yi Hengzhong, Wen Xinmin, Tang Zhigang, Huang Sheng, Li Yao, Chen Mengshi, Rong Pengfei. Study on the association between gut microbiota and drug-induced liver injury in patients with drug-resistant pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1277-1289. |
| [6] | Xu Chaoyan, Wei Jiaojiao, Li Shanshan, Yao Lin, Li Ling, Gao Mengqiu. Construction and clinical evaluation of an early diagnostic model for Mycobacterium intracellulare pulmonary disease [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1290-1299. |
| [7] | Ma Liang, Ilyar Batyr, Gu Fuding, Tang Wei, Zhou Wenzheng, Dilixiati Abulizi, Mierzhati Aisha, Qin Wei. Retrospective analysis of 21 cases of advanced knee tuberculosis treated with one-stage radical debridement and total knee arthroplasty [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1300-1306. |
| [8] | Zhang Aihua, Xu Meng, Yang Yuying, Su Shuang, Song Lei, Ma Dandan, Wei Suxia, Cheng Junwei, Fu Chaohong. Analysis of the incidence of anemia and related risk factors in 878 AIDS patients with tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1307-1314. |
| [9] | Xue Yunlian, Li Sijie, Jiang Xue, Liu Guihao, Wu Huizhong, Wang Tingting, Zhou Zhanqi, Ji Lianrong, Wang Jiawen, Wu Xinghua, Wu Yue, Zhou Lin. Global, regional, and national burdens of tuberculosis attributable to smoking from 1990 to 2021 [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1315-1323. |
| [10] | Huang Liping, Gu Wenju, Bao Peiyu, Shen Jiayi, Song Yanzheng, Zhang Lin. The current status and influencing factors of preoperative anxiety in patients with cervical lymph node tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1324-1330. |
| [11] | Zhao Yuchuan, Chen Yanmei, Zhang Chenchen, Yu Meiling, Peng Kehao, Xu Liuyue, Liang Hongdi, Chen Xunxun. Research on performance comparison and selection strategies of digital PCR platforms for tuberculosis detection [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1331-1337. |
| [12] | Gulijiamali Rexiding, Gulina Badeerhan, Wang Mingzhe, Paziliya Aini, Yipar Aihaiti, Wang le, Liu Nianqiang, Dong Xiao, Wang Senlu. Predictive value of ARIMA model and Holt-Winters exponential smoothing method for pulmonary tuberculosis incidence in Xinjiang Uygur Autonomous Region [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1338-1345. |
| [13] | Xie Cifu, Song Lixin, Yin Pengliang, Xiong Zi. Evaluation of the intervention effect of an online prize-winning quiz on residents’ core knowledge of pulmonary tuberculosis prevention and control [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1356-1363. |
| [14] | Zhou Ran, Deng Jing, Chen Haiyi, Zhang Ting, Zheng Denghu. Risk prediction of catastrophic household cost among patients with rifampicin-susceptible pulmonary tuberculosis in Chongqing Municipality [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1364-1374. |
| [15] | Huang Quanjiang, Huang Minying, Cui Zhezhe. Quality evaluation of tuberculosis prevention and control work in Guangxi based on Entropy Weight-TOPSIS and RSR method [J]. Chinese Journal of Antituberculosis, 2026, 48(9): 1375-1385. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.